Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Stock Information for Tonix Pharmaceuticals Holding Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA(TM) and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Tonix Pharmaceuticals to Present Poster on Tonmya(TM) at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.